Have you tested positive for COVID-19?

 

FDA Restricts Use of Monoclonal Antibody Sotrovimab to Treat COVID-19 Due to the Omicron BA.2 Variant

Cost? Check with your insurance company or healthcare provider for information about costs for mAb services.

MAbs are authorized by the FDA to treat patients with mild to moderate COVID-19. The treatments are done by intravenous (IV) infusion in an outpatient setting. Therapeutic antibody treatments play an important role in Louisiana's ongoing COVID-19 response.

Patient Information Provider Information

National Monoclonal Therapeutics Distribution Locations

Helpful Resources